Ampco Pittsburgh Corp: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 14, 2022 and accepted by EDGAR at Nov 14, 2022, 14:42 ET.
Management's discussion and analysis
As filed, 34,204 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(in thousands, except share and per share amounts)
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by us or on behalf of Ampco-Pittsburgh Corporation (the “Corporation”). Management’s Discussion and Analysis of Financial Condition and Results of Operations and other sections of this Quarterly Report on Form 10-Q, as well as the condensed consolidated financial statements and notes hereto, may include, but are not limited to, statements about operating performance, trends and events that we expect or anticipate will occur in the future, statements about sales and production levels, restructurings, the impact from global pandemics (including COVID-19) and international conflicts, profitability and anticipated expenses, inflation, the global supply chain, future proceeds from the exercise of outstanding warrants, and cash outflows. All statements in this document other than statements of historical fact are statements that are, or could be, deemed “forward-looking statements” within the meaning of the Act and words such as “may,” “will,” “intend,” “believe,” “expect,” “anticipate,” “estimate,” “project,” “forecast,” and other terms of similar meaning that indicate future events and trends are also generally intended to identify forward-looking statements. Forward-looking statements speak only as of the date on which such statements are made, are not guarantees of future performance or expectations, and involve risks and uncertainties. For us, these risks and uncertainties include, but are not limited to:
- economic downturns, cyclical demand for our products and insufficient demand for our products,
- excess global capacity in the steel industry,
- fluctuations in the value of the U.S. dollar relative to other currencies,
- increases in commodity prices or insufficient hedging against increases in commodity prices, reductions in electricity and natural gas supply or shortages of key production materials for us or our customers,
- limitations in availability of capital to fund our strategic plan,
- inability to maintain adequate liquidity to meet our operating cash flow requirements, repay maturing debt and meet other financial obligations,
- inability to obtain necessary capital or financing on satisfactory terms to acquire capital expenditures that may be necessary to support our growth strategy,
- inoperability of certain equipment on which we rely,
- liability of our subsidiaries for claims alleging personal injury from exposure to asbestos-containing components historically used in certain products of our subsidiaries,
- changes in the existing regulatory environment,
- inability to successfully restructure our operations,
- consequences of global pandemics (including COVID-19) and international conflicts,
- work stoppage or another industrial action on the part of any of our unions,
- inability to satisfy the continued listing requirements of the New York Stock Exchange or the NYSE American Exchange,
- potential attacks on information technology infrastructure and other cyber-based business disruptions,
- failure to maintain an effective system of internal control, and
- those discussed more fully elsewhere in this report and in documents filed with the Securities and Exchange Commission by us, particularly in Item 1A, Risk Factors, in Part I of our latest Annual Report on Form 10-K for the year ended December 31, 2021.
We cannot guarantee any future results, levels of activity, performance or achievements. In addition, there may be events in the future that we are not able to predict accurately or control which may cause actual results to differ materially from expectations expressed or implied by forward-looking statements. Except as required by applicable law, we assume no obligation, and disclaim any obligation, to update forward-looking statements whether as a result of new information, events or otherwise.
The Business
Ampco-Pittsburgh Corporation and its subsidiaries (collectively, the “Corporation”) manufacture and sell highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments – the *Forged and Cast Engineered Products (“*FCEP”) segment and the *Air and Liquid Processing (“*ALP”) segment. This segment presentation is consistent with how the Corporation’s chief operating decision maker evaluates financial performance and makes resource allocation and strategic decisions about the business.
The FCEP segment produces forged hardened steel rolls, cast rolls and forged engineered products (“FEP”). Forged hardened steel rolls are used primarily in cold rolling mills by producers of steel, aluminum and other metals. Cast rolls, which are produced in a variety of iron and steel qualities, are used mainly in hot and cold strip mills, medium/heavy section mills and plate mills. FEP principally are sold to customers in the steel distribution market, oil and gas industry and the aluminum and plastic extrusion industries. The segment has operations in the United States, England, Sweden, and Slovenia, and an equity interest in three joint venture companies in China. Collectively, the segment primarily competes with European, Asian and North and South American companies in both domestic and foreign markets and distributes a significant portion of its products through sales offices located throughout the world.
The ALP segment includes Aerofin, Buffalo Air Handling and Buffalo Pumps, all divisions of Air & Liquid Systems Corporation (“Air & Liquid”), a wholly owned subsidiary of the Corporation. Aerofin produces custom-engineered finned tube heat exchange coils and related heat transfer products for a variety of industries including OEM/commercial, nuclear power generation and industrial manufacturing. Buffalo Air Handling produces large custom-designed air handling systems for institutional (e.g., hospital, university), pharmaceutical and general industrial building markets. Buffalo Pumps manufactures centrifugal pumps for the fossil-fueled power generation, marine defense and industrial refrigeration industries. The segment has operations in Virginia and New York with headquarters in Carnegie, Pennsylvania. The segment distributes a significant portion of its products through a common independent group of sales offices located throughout the United States and Canada.
Executive Overview
While the Corporation is operating at more normal levels following the emergence of the coronavirus (“COVID-19”) pandemic in 2020, lingering effects continue, some of which are being exacerbated by the Russia-Ukraine conflict, including:
- Periodic disruptions to the global supply chain for the Corporation and its customers,
- Global inflationary pressures and
- Delays in receiving and shipping product due to the lack of transportation.
The Corporation is actively monitoring, and will continue to actively monitor, the pandemic and the Russia-Ukraine conflict and the potential impact on its operations, financial condition, liquidity, suppliers, industry, and workforce.
For the FCEP segment, roll market conditions have recovered to pre-pandemic levels. The FEP market also has strengthened with increasing demand from the steel distribution and oil and gas markets, on rising oil prices. Although the segment continues to be adversely impacted by escalating costs, particularly for raw and ancillary materials, energy and transportation, price increases and changes to surcharge policies announced in the fourth quarter of 2021 are absorbing a significant portion of these costs, albeit on a lag. Approximately 75% of customer orders include a commodity surcharge. The primary focus for this segment is to maintain a strong position in the roll and FEP markets, diversify and develop FEP for use in other industries, complete operational and efficiency improvements at its facilities, and upgrade existing equipment with a goal of reducing costs, improving reliability and increasing FEP capacity and capabilities.
For the ALP segment, the businesses are benefitting from increasing demand but, similarly, are facing increasing production and transportation costs and supply chain issues. The segment has been implementing price increases for certain of its products to help mitigate these inflationary effects. The focus for this segment is to grow revenues, strengthen engineering and manufacturing capabilities and continue to improve its sales distribution network.
Selected Financial Information
| Net Sales: | Three Months Ended September 30, 2022 | 2021 | Change | Nine Months Ended September 30, 2022 | 2021 | Change |
|---|---|---|---|---|---|---|
| Forged and Cast Engineered Products | $75,511 | $61,179 | $14,332 | $229,848 | $195,558 | $34,290 |
| Air and Liquid Processing | 24,136 | 20,006 | 4,130 | 66,807 | 64,855 | 1,952 |
| Consolidated | $99,647 | $81,185 | $18,462 | $296,655 | $260,413 | $36,242 |
| (Loss) Income from Operations: | ||||||
| Forged and Cast Engineered Products | $(62) | $(2,832) | $2,770 | $1,107 | $688 | $419 |
| Air and Liquid Processing | 2,917 | 2,891 | 26 | 8,177 | 7,265 | 912 |
| Corporate costs | (2,929) | (2,420) | (509) | (8,435) | (8,938) | 503 |
| Consolidated | $(74) | $(2,361) | $2,287 | $849 | $(985) | $1,834 |
| September 30, 2022 | December 31, 2021 | Change | ||||
| Backlog: | ||||||
| Forged and Cast Engineered Products | $227,534 | $223,321 | $4,213 | |||
| Air and Liquid Processing | 106,117 | 69,233 | 36,884 | |||
| Consolidated | $333,651 | $292,554 | $41,097 |
Net sales approximated $99,647 and $81,185 for the three months ended September 30, 2022, and 2021, respectively, and $296,655 and $260,413 for the nine months ended September 30, 2022, and 2021, respectively. The increase primarily is attributable to higher sales for the FCEP segment. A discussion of net sales for the Corporation’s two segments is included below.
(Loss) income from operations approximated $(74) and $(2,361) for the three months ended September 30, 2022, and 2021, respectively, and $849 and $(985) for the nine months ended September 30, 2022, and 2021, respectively. Included in (loss) income from operations for the nine months ended September 30, 2022, is a charge of approximately $664 for excess COVID-19 subsidies received in 2020 but returned in 2022 (“the Refund of Excess COVID-19 Subsidies”) and a benefit of approximately $1,431 resulting from a change in how certain employees earn certain benefits (the “Change in Employee Benefit Policy”). A discussion of (loss) income from operations for the Corporation’s two segments is included below. Corporate costs decreased for the nine months ended September 30, 2022, when compared to the nine months ended September 30, 2021, due to lower employee-related costs including lower incentive compensation and a portion of the benefit from the Change in Employee Benefit Policy being attributable to Corporate employees.
Backlog equaled $333,651 as of September 30, 2022, versus $292,554 as of December 31, 2021. Backlog represents the accumulation of firm orders on hand which: (i) are supported by evidence of a contractual arrangement, (ii) include a fixed and determinable sales price, (iii) have collectability that is reasonably assured, and (iv) generally are expected to ship within two years from the backlog reporting date. Backlog at a certain date may not be a direct measure of future revenue for a particular order because price increases, negotiated subsequently to the original order, are not included in backlog until the updated contract is received from the customer and certain surcharges are not determinable until the order is completed and ready for shipment to the customer. Approximately 60% of the backlog is expected to be released after 2022. A discussion of backlog by segment is included below.
Costs of products sold, excluding depreciation and amortization, as a percentage of net sales, for the three months ended September 30, 2022, and 2021, approximated 84.7% and 83.7%, respectively. While gross margins were slightly better for the FCEP segment for the third quarter of 2022 when compared to the third quarter of 2021, gross margins for the ALP segment were slightly less as a result of an unfavorable product mix. Costs of products sold, excluding depreciation and amortization, as a percentage of net sales, for the nine months ended September 30, 2022, and 2021, approximated 84.5% and 81.8%, respectively. The increase was primarily attributable to the FCEP segment which experienced higher costs, particularly for direct and indirect materials, energy and transportation when compared to the same period of the prior year. Although a portion of these costs are recovered via the variable-index surcharge, there is a lag between the time the costs are incurred and the time the variable-index surcharge is invoiced to the customer.
Selling and administrative expenses were comparable for the three months ended September 30, 2022, and 2021, and approximated $11,089 and $10,910, respectively. Selling and administrative expenses for the nine months ended September 30, 2022, and 2021, approximated $31,941 and $34,538, respectively, a decrease of $2,597. The decrease primarily is attributable to:
- Lower exchange rates used to translate the selling and administrative costs of the Corporation’s foreign subsidiaries into the U.S. dollar, which reduced selling and administrative expenses by approximately $1,200 for nine months ended September 30, 2022, when compared to the prior year, and,
- Benefit from the Change in Employee Benefit Policy, which reduced selling and administrative expenses by approximately $1,020 for the nine months ended September 30, 2022.
Investment-related income relates primarily to dividends from one of the Corporation’s Chinese joint ventures. In the third quarter of 2022, the Chinese joint venture declared a dividend which equaled $504 for the Corporation. In the second quarter of 2021, the Chinese joint venture declared a dividend which equaled $1,025 for the Corporation.
Interest expense approximated $1,486 and $834 for the three months ended September 30, 2022, and 2021, respectively, and $3,684 and $2,672 for the nine months ended September 30, 2022, and 2021, respectively. The increase for each of the current year periods when compared to the same periods of the prior year is principally due to higher average borrowings outstanding under the revolving credit facility and higher interest rates.
Other income – net is comprised of the following:
| Three Months Ended September 30, 2022 | 2021 | Change | Nine Months Ended September 30, 2022 | 2021 | Change | |
|---|---|---|---|---|---|---|
| Net pension and other postretirement income | $1,631 | $1,672 | $(41) | $4,931 | $5,015 | $(84) |
| Gain (loss) on foreign exchange transactions | 1,809 | 369 | 1,440 | 3,368 | (705) | 4,073 |
| Unrealized (loss) gain on Rabbi trust investments | (276) | (56) | (220) | (1,292) | 359 | (1,651) |
| Other | 10 | 21 | (11) | 12 | 25 | (13) |
| $3,174 | $2,006 | $1,168 | $7,019 | $4,694 | $2,325 |
Other income – net fluctuated period over period due to changes in foreign exchange gains and losses and, as a result of recent volatility in the financial markets, unrealized losses in the market value of the Rabbi trust investments.
Income tax provision for each of the periods includes income taxes associated with the Corporation’s profitable operations. An income tax benefit is not able to be recognized on losses of certain of the Corporation’s entities since it is “more likely than not” the asset will not be realized. Accordingly, changes in the income tax provision for each of the periods include the effects of changes in the pre-tax income of the Corporation’s profitable operations. In addition, the income tax provision for the three and nine months ended September 30, 2022, includes expense of $316 resulting from the revaluation of certain deferred tax assets associated with the Pennsylvania tax rate change. By comparison, the income tax provision for the nine months ended September 30, 2021, includes $523 of expense associated with the (i) restructuring of a foreign sales office and (ii) revaluation of the deferred income taxes of the Corporation’s U.K. entity following new legislation enacted in 2021, which will increase the U.K. corporate tax rate from 19% to 25% in 2023.
Net income attributable to Ampco-Pittsburgh and income (loss) per common share attributable to Ampco-Pittsburgh equaled $846 and $0.04 per common share and $2,894 and $0.15 per common share for the three and nine months ended September 30, 2022, respectively, and $(1,589) and $(0.08) per common share and $(359) and $(0.02) per common share for the three and nine months ended September 30, 2021, respectively.
Net income attributable to Ampco-Pittsburgh and income per common share attributable to Ampco-Pittsburgh for the nine months ended September 30, 2022, include a net benefit of $427 or $0.02 per common share for:
- The after-tax benefit from the Change in Employee Benefit Policy of $1,407 offset by
- The after-tax charge associated with the Refund of Excess COVID-19 Subsidies of $664 and
- The revaluation of certain deferred income tax assets associated with the change in the Pennsylvania state income tax rate of $316.
Net (loss) attributable to Ampco-Pittsburgh and (loss) per common share attributable to Ampco-Pittsburgh for the nine months ended September 30, 2021, include net expense of $522 or $0.03 per common share for (i) the restructuring of a foreign sales office and (ii) the revaluation of the deferred income taxes of the Corporation’s U.K. entity following new legislation enacted in 2021, which will increase the U.K. corporate tax rate from 19% to 25% in 2023.
Net Sales and Operating Results by Segment
Forged and Cast Engineered Products
| Net Sales: | Three Months Ended September 30, 2022 | 2021 | Change | Nine Months Ended September 30, 2022 | 2021 | Change |
|---|---|---|---|---|---|---|
| Forged and cast mill rolls | $66,653 | $53,778 | $12,875 | $193,946 | $177,918 | $16,028 |
| FEP | 8,858 | 7,401 | 1,457 | 35,902 | 17,640 | 18,262 |
| $75,511 | $61,179 | $14,332 | $229,848 | $195,558 | $34,290 | |
| (Loss) Income from Operations | $(62) | $(2,832) | $2,770 | $1,107 | $688 | $419 |
| September 30, 2022 | December 31, 2021 | Change | ||||
| Backlog | $227,534 | $223,321 | $4,213 |
Net sales increased for each of the current year periods when compared to the same periods of the prior year principally due to:
- Higher pricing and variable-index surcharges passed through to customers as a result of higher raw material, energy and transportation costs, which increased net sales by $15,400 and $42,800 for the three and nine months ended September 30, 2022, respectively,
- Higher volume of mill roll shipments primarily resulting from the timing of deliveries, which increased net sales by approximately $8,600 and $4,800 for the three and nine months ended September 30, 2022, respectively,
- Higher volume of FEP shipments as a result of increased demand from the steel distribution and oil and gas markets, which increased net sales by approximately $4,600 for the nine months ended September 30, 2022, but decreased net sales by approximately $2,600 for the three months then ended,
- Changes in product mix, which decreased net sales by $1,800 and $6,600 for the three and nine months ended September 30, 2022, respectively, and
- Changes in exchanges rates used to translate net sales of the segment’s foreign subsidiaries into the U.S. dollar, which decreased net sales by approximately $5,300 and $11,300 for the three and nine months ended September 30, 2022, respectively.
Operating results for the current year periods improved when compared to the same periods of the prior year. While the segment continues to experience escalating costs for raw and ancillary materials, energy, transportation, direct labor and other items, a significant portion of these increases was recovered via the variable-index surcharge mechanism and higher pricing. The variable-index surcharge is known at the time of shipment and increases or decreases, as applicable, the selling price of the product for the corresponding changes in the published index cost of certain raw materials and energy. The variable-index surcharge is recognized as revenue when the corresponding sale of the inventory is recognized. However, since the cost of domestic raw materials, work-in-process and finished goods is primarily determined by the last-in, first-out method, the higher or lower costs of those certain raw materials and energy are recognized prior to the variable-index surcharge thus creating a lag between the time these costs are incurred and the time these costs are recovered.
For the three months ended September 30, 2022, the improved pricing and variable-indexed surcharge exceeded the higher raw material, energy and transportation costs by approximately $800 but, for the nine months ended September 30, 2022, under-recovered by approximately $2,100 when compared to the same period of the prior year.
In addition, (loss) income from operations improved for each of the current year periods when compared to the same periods of the prior year due to:
- Higher volume of shipments, which had a net improvement on operating results of $1,400 and $1,500 for the three and nine months ended September 30, 2022, respectively,
- Lower selling and administrative costs of approximately $700 and $2,100 for the three and nine months ended September 30, 2022, respectively, including the savings generated from the Change in Employee Benefit Policy of $562 for the nine months ended September 30, 2022,
- Lower losses on the sale of equipment of approximately $300 for the three and nine months ended September 30, 2022, offset by
- Expense associated with the Refund of Excess COVID-19 Subsidies in the second quarter of 2022 of $664, and
- Changes in exchanges rates used to translate the operating results of the segment’s foreign subsidiaries into the U.S. dollar, which reduced operating results by approximately $360 and $620 for the three and nine months ended September 30, 2022, respectively.
Backlog increased slightly at September 30, 2022, from December 31, 2021, by $4,213. The backlog of orders for rolls increased at September 30, 2022, from December 31, 2021, by approximately $31,800 due to improved demand from flat-rolled steel and aluminum customers and improved pricing. The backlog of orders for FEP decreased at September 30, 2022, from December 31, 2021, by approximately $11,500 due to timing of receipt of new orders from customers. Lower foreign exchange rates used to translate the backlog of the Corporation’s foreign subsidiaries into the U.S. dollar also reduced backlog at September 30, 2022, when compared to backlog at December 31, 2021, by approximately $16,100. At September 30, 2022, approximately 59% of backlog is expected to ship after 2022.
Air and Liquid Processing
| Net Sales: | Three Months Ended September 30, 2022 | 2021 | Change | Nine Months Ended September 30, 2022 | 2021 | Change |
|---|---|---|---|---|---|---|
| Heat exchange coils | $8,532 | $6,527 | $2,005 | $22,483 | $18,482 | $4,001 |
| Air handling systems | 8,457 | 6,383 | 2,074 | 22,133 | 21,235 | 898 |
| Centrifugal pumps | 7,147 | 7,096 | 51 | 22,191 | 25,138 | (2,947) |
| $24,136 | $20,006 | $4,130 | $66,807 | $64,855 | $1,952 | |
| Income from Operations | $2,917 | $2,891 | $26 | $8,177 | $7,265 | $912 |
| September 30, 2022 | December 31, 2021 | Change | ||||
| Backlog | $106,117 | $69,233 | $36,884 |
Net sales for the three and nine months ended September 30, 2022, improved over the comparable prior year periods by $4,130 and $1,952, respectively. More specifically,
- Sales of heat exchange coils benefited from a higher volume of shipments to commercial and industrial customers and
- Sales of air handling systems improved due to increased order intake, while
- Sales of centrifugal pumps were adversely affected by supply chain delays for purchased components and customer delays.
Operating income benefitted from the higher sales but was offset by unfavorable product mix, particularly in the third quarter of 2022. Operating income for the for the nine months ended September 30, 2022, includes a benefit from the Change in Employee Benefit Policy of $680.
Backlog at September 30, 2022, increased from December 31, 2021, by $36,884 with backlog for each product line improving as a result of record-level order intake. In particular, the segment received a $9,600 order for a custom air handling unit project with a major healthcare provider which is expected to ship in 2023. At September 30, 2022, approximately 64% of backlog is expected to ship after 2022.
Non-GAAP Financial Measures
The Corporation presents non-GAAP adjusted (loss) income from operations, which is calculated as (loss) income from operations excluding the Refund of Excess COVID-19 Subsidies and the Change in Employee Benefit Policy. This non-GAAP financial measure is not based on any standardized methodology prescribed by accounting principles generally accepted in the United States of America (“GAAP”) and may not be comparable to similarly titled measures presented by other companies.
The Corporation has presented non-GAAP adjusted (loss) income from operations because it is a key measure used by the Corporation’s management and Board of Directors to understand and evaluate the Corporation’s operating performance and to develop operational goals for managing its business. This non-GAAP financial measure excludes significant charges or credits, that are one-time charges or credits, unrelated to the Corporation’s ongoing results of operations or beyond its control. Additionally, a portion of the incentive and compensation arrangements for certain employees is based on the Corporation’s business performance. The Corporation believes this non-GAAP financial measure helps identify underlying trends in its business that could otherwise be masked by the effect of the items that it excludes from adjusted (loss) income from operations. The Corporation also believes this non-GAAP financial measure provides useful information to management, shareholders and investors, and others in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects and allowing for greater transparency with respect to key financial metrics used by the Corporation’s management in its financial and operational decision-making.
Adjusted (loss) income from operations is not prepared in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are limitations related to the use of adjusted (loss) income from operations rather than (loss) income from operations, which is the nearest GAAP equivalent. Among other things, there can be no assurance that charges similar to the Refund of Excess COVID-19 Subsidies and benefits similar to the Change in Employee Benefit Policy will not occur in future periods.
The adjustments reflected in adjusted (loss) income from operations are pre-tax. The tax impact associated with the adjustments is not significant, approximately $24, due to the Corporation having a valuation allowance recorded against the deferred income tax assets for the majority of the jurisdictions where the expense and income are recognized.
The following is a reconciliation of (loss) income from operations to non-GAAP adjusted (loss) income from operations for the three and nine months ended September 30, 2022, and 2021, respectively:
| Three Months Ended September 30, 2022 | 2021 | Nine Months Ended September 30, 2022 | 2021 | |
|---|---|---|---|---|
| (Loss) income from operations, as reported (GAAP) | $(74) | $(2,361) | $849 | $(985) |
| Refund of Excess COVID-19 Subsidies (1) | 0 | 0 | 664 | 0 |
| Change in Employee Benefit Policy (2) | 0 | 0 | (1,431) | 0 |
| (Loss) income from operations, as adjusted (Non-GAAP) | $(74) | $(2,361) | $82 | $(985) |
(1) Represents excess COVID-19 subsidies received in 2020 and returned in 2022.
(2) Represents a benefit resulting from a change in how certain employees earn certain benefits.
Liquidity and Capital Resources
| Nine Months Ended September 30, 2022 | 2021 | Change | |
|---|---|---|---|
| Net cash flows used in operating activities | $(20,405) | $(4,398) | $(16,007) |
| Net cash flows used in investing activities | (12,516) | (11,521) | (995) |
| Net cash flows provided by financing activities | 35,908 | 11,609 | 24,299 |
| Effect of exchange rate changes on cash and cash equivalents | (1,134) | (281) | (853) |
| Net increase (decrease) in cash and cash equivalents | 1,853 | (4,591) | 6,444 |
| Cash and cash equivalents at beginning of period | 10,337 | 16,842 | (6,505) |
| Cash and cash equivalents at end of period | $12,190 | $12,251 | $(61) |
Net cash flows used in operating activities equaled $(20,405) and $(4,398) for the nine months ended September 30, 2022, and 2021, respectively. The significant change between the years primarily is due to the ongoing investment in trade working capital due to a higher level of business activity resulting from increased demand and, for inventories, higher costs associated with inflation and supply chain disruptions.
Net cash flows used in investing activities equaled $(12,516) and $(11,521) for the nine months ended September 30, 2022, and 2021, respectively. Capital expenditures for each of the periods were relatively comparable and related primarily to the FCEP segment. The Corporation has undertaken a significant capital program approximating $27,000 to upgrade existing equipment at certain of its FCEP locations, which is anticipated to be completed by December 31, 2023. At September 30, 2022, commitments for future capital expenditures, including those associated with the FCEP capital program, approximated $19,300.
Net cash flows provided by financing activities equaled $35,908 and $11,609 for the nine months ended September 30, 2022, and 2021, respectively. The change period over period primarily is due to:
- Net borrowings from the Corporation’s revolving credit facility of $15,717 versus $10,516 in the prior year,
- Proceeds from a sale and leaseback financing transaction completed in the third quarter of 2022 equaling $15,500,
- Proceeds from an equipment financing facility completed in the third quarter of 2022, which provided proceeds of $4,014,
- Net borrowings from one of the Corporation’s Chinese joint ventures from its minority shareholder of $1,525 for the nine months ended September 30, 2022, in comparison to repayments of $1,065 for the nine months ended September 30, 2021, offset by
- Lower proceeds from shareholders exercising warrants for the Corporation’s common stock of $3,308.
The effect of exchange rate changes on cash and cash equivalents is primarily attributable to the fluctuation of the British pound and Swedish krona against the U.S. dollar.
As a result of the above, cash and cash equivalents increased by $1,853 during 2022 and ended the period at $12,190 in comparison to $10,337 at December 31, 2021. The majority of the Corporation’s cash and cash equivalents is held by its foreign operations. Domestic customer remittances are used to pay down borrowings under the Corporation’s revolving credit facility daily, resulting in minimal cash maintained by the Corporation’s domestic operations. Cash held by the Corporation’s foreign operations is considered to be permanently re-invested; accordingly, a provision for estimated local and withholding tax has not been made. If the Corporation were to remit any foreign earnings to it or any of its U.S. entities, the estimated tax impact would be insignificant.
Funds on hand, funds generated from future operations and availability under the Corporation’s revolving credit facility are expected to be sufficient to finance the Corporation’s operational requirements and debt service costs. The maturity date for the revolving credit facility is June 29, 2026, and, subject to the other terms and conditions of the revolving credit agreement, will become due on that date. As of September 30, 2022, remaining availability under the revolving credit facility approximated $35,622, net of standard availability reserves.
Availability under the Corporation’s equipment financing facility and the Disbursement Agreement are expected to be sufficient to finance the capital program for the FCEP segment in the timeframe currently anticipated. At September 30, 2022, availability under the equipment financing facility and Disbursement Agreement approximated $18,500. Each borrowing on the equipment financing facility will constitute a secured loan transaction (each, a “Term Loan”). Each Term Loan will convert to a Term Note on the earlier of (i) the date in which the associated equipment is placed in service or (ii) December 31, 2023. Each Term Note will have a term of 84 months in arrears fully amortizing and will commence on the date of the Term Note. Borrowings under the Disbursement Agreement will be repaid over an initial term of 20 years – through August 2042.
Litigation and Environmental Matters
See Note 15 and Note 16 to the condensed consolidated financial statements.
Critical Accounting Pronouncements
The Corporation’s critical accounting policies, as summarized in its Annual Report on Form 10-K for the year ended December 31, 2021, remain unchanged.
Recently Issued Accounting Pronouncements
See Note 1 to the condensed consolidated financial statements.
Controls and procedures
As filed, 1,859 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Disclosure controls and procedures. An evaluation of the effectiveness of the Corporation’s disclosure controls and procedures as of the end of the period covered by this report was carried out under the supervision, and with the participation, of management, including the principal executive officer and principal financial officer. Disclosure controls and procedures are defined under Securities and Exchange Commission (“SEC”) rules as controls and other procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) is recorded, processed, summarized and reported within the required time periods. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, the Corporation’s management, including the principal executive officer and principal financial officer, has concluded that the Corporation’s disclosure controls and procedures were effective as of September 30, 2022.
Changes in Internal Control. There has been no change in the Corporation’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Exchange Act that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.
Risk factors
As filed, 183 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There are no material changes to the Risk Factors contained in Item 1A to Part I of the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2021.
Items 2-5 None.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $97.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $289.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 3 months2022-07-01 to 2022-09-30 | $11.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-01-01 to 2022-09-30 | $31.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-07-01 to 2022-09-30 | −$74.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-01 to 2022-09-30 | $849.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $987.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $1.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | $846.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | $2.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-07-01 to 2022-09-30 | $0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-01-01 to 2022-09-30 | $0.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | $0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | $0.15 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-01 to 2022-09-30 | 19,522,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-01 to 2022-09-30 | 19,473,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | −$20.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-01 to 2022-09-30 | $13.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-09-30 | $12.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-09-30 | $204.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $484.4m | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $119.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-09-30 | $406.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-09-30 | $69.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-22-037585. Last ingested by Listed: Nov 10, 2026, 16:42 ET. Listed shows no prices and gives no investment advice.